Quest Laborato, a company in the Pharmaceuticals industry, reported revenue of ₹55 crore and net profit of ₹9.00 crore for the September 2026 quarter.
Quest Laborato. (NSE: QUESTLAB-SM) closed at ₹92.00 on 20 Nov 2026, up 3.4% over the past year. Its market capitalisation is ₹151 crore and it trades at 9.5 times earnings.
Incorporated in 1998, Quest Laboratories Ltd is a pharmaceutical manufacturer specializing in diverse therapeutic segments
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.